# Interpretation and Recommendations
Executed Python results (synthetic): 4,000 patients, 1,984 MACE events (49.6%), median MACE-free 71.5 months, 12-month BP control 83.0%.
- **Glycemic control (linear).** Twelve-month HbA1c is driven mostly by baseline HbA1c (beta about 0.99, R^2 about 0.84). After adjustment, better adherence and statin use are associated with lower 12-month HbA1c and current smoking with higher values -- the modifiable levers once baseline risk is accounted for.
- **BP control (logistic).** Antihypertensive use is the dominant correlate of control (aOR about 6.9); higher baseline SBP works against it (aOR about 0.80); adherence helps.
- **Cardiovascular risk (survival).** Diabetes (HR about 1.74), older age, male sex, and higher SBP/LDL raise MACE hazard; statin use is protective (HR about 0.85).
- **Temporal pattern (time series).** Monthly MACE counts carry a trend plus a synthetic seasonal component; the Holt-Winters forecast extends 12 months.

**For a program team:** treat this as a workflow demonstration. In real data, act on modifiable factors (adherence, treatment intensification, smoking) only after checking data quality, confirming model assumptions, and -- because patients recur over calendar time -- considering clustered/robust standard errors and competing-risk or time-varying extensions.
